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Abstract
Two hepatitis B virus (HBV) C/D recombinants were isolated from western China. No direct evidence indicates that these
new viruses arose as a result of recombination between genotype C and D or a result of convergence. In this study, we
search for evidence of intra-individual recombination in the family cluster cases with co-circulation of genotype C, D and C/
D recombinants. We studied 68 individuals from 15 families with HBV infections in 2006, identified individuals with mixed
HBV genotype co-infections by restriction fragment length polymorphism and proceeded with cloning and DNA
sequencing. Recombination signals were detected by RDP3 software and confirmed by split phylogenetic trees. Families
with mixed HBV genotype co-infections were resampled in 2007. Three of 15 families had individuals with different HBV
genotype co-infections in 2006. One individual (Y2) had a triple infection of HBV genotype C, D and C/D recombinant in
2006, but only genotype D in 2007. Further clonal analysis of this patient indicated that the C/D recombinant was not
identical to previously isolated CD1 or CD2, but many novel recombinants with C2, D1 and CD1 were simultaneously found.
All parental strains could recombine with each other to form new recombinant in this patient. This indicates that the
detectable mixed infection and recombination have a limited time window. Also, as the recombinant nature of HBV
precludes the possibility of a simple phylogenetic taxonomy, a new standard may be required for classifying HBV
sequences.
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Introduction
Not all viruses are equally prone to recombination. Re-
combination has not been detected in several viruses despite
repeated searches [1]. Whether recombination does or does not
exist is important for understanding the evolution and replication
mechanism of a specific kind of virus. Hepatitis B virus (HBV),
a major human pathogen, has been classified into 10 genotypes
and several sub-genotypes [2,3]. Many sub-genotypes were
identified by polygenetic analysis as recombinants. But there is
no direct evidence to indicate that these subgenotypes arose as
a result of recombination or perhaps a result of convergence.
Coinfection with different HBV genotype strains is a prerequisite
for recombination. As more than one genotype is predominant in
most of the geographic regions, coinfection between the pre-
dominating HBV genotypes is not a rare finding, especially for B
and C, or A and D. The prevalence of mixed HBV genotype
infections has been reported using varied genotyping methods
[4,5,6].
Our previous study found two kinds of HBV C/D recombi-
nants in northwest China [7]. In a further study of ethnic groups
of five provinces, we confirmed the geographic and ethnic
distribution of the HBV C/D recombinant in northwest China
[8], and found that family-cluster HBV infections were common
in these endemic areas. We hypothesize that infected members of
HBV family clusters would gain exposure to various genotypes
through marriage, while at the same time; competent strains
would be selected through vertical transmission. It would be
useful to observe the mixed infection in family-cluster cases,
especially in patients infected with C/D recombinants.
The aim of this study was to evaluate the possibility of
recombination between two HBV genotypes within an individual
by finding cluster-infected families in which individual members
were infected with different HBV genotypes. We would then look
for individuals within these families with multiple-genotypes that
were likely to have been obtained from other family members as
a result of vertical or horizontal transmission. Novel viral genomes
within an individual with a multiple genotype infection that were
mosaics of the known viral genotypes in the family, but not present
in any of the other family members, would be consistent with the
hypothesis that they arose within the individual with multiple
genotype infections.
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Subjects
We enrolled 68 patients with a chronic HBV infection from 15
families. All the families were from a district located at the
boundary of Gansu and Qinghai provinces, where the prevalence
of genotype C2, D1 and C/D recombinant HBV were known to
be high [8]. The families were initially identified with cluster HBV
infection in an epidemiological survey in 2002. Sixty-eight
individuals were sampled in June 2006 and December 2007 for
the purpose of assigning HBV genotypes to chronically infected
individuals and finding individuals with multiple HBV genotype
co-infections. None of the patients received anti-viral therapy or
immunosuppressant drugs. A written, informed consent was
obtained from each family, and the study protocol was approved
by the Southern Medical University Ethics Committee.
HBV DNA Extraction and HBV Genotyping
HBV DNA was extracted from 400 mL of serum by QIAamp
UltraSens Virus Kit (Qiagen GmbH, Germany), then re-
suspended in 50 mL water and stored at 220uC until analysis.
HBV genotypes, including C/D recombinant, were initially
assigned using the PCR based restriction fragment length poly-
morphism (RFLP) methods described previously [9], [8].
Cloning of Mixed Infection Samples
For samples with mixed genotype infections, PCR cover HBV S
gene (nt136-1110) was performed using the primers and thermo-
cycling conditions descirbed by Sugauchi et al [10]. For samples
needing further recombination analysis, PCR was performed using
the primers and thermocycling conditions described by Gu ¨nther to
obtain full-length HBV genome [11]. Alternatively, a nested PCR
was used to produce two overlapping fragments in subjects with
low HBV DNA levels as described by Sugauchi et al [12]. The
spanning of fragment A cover nucleotides 2813 to 1824, and
fragment B included nucleotides 1821 to 237. LA-Taq (TAKARA,
Japan) and high-fidelity polymerase COD-FX (TOYOBO, Japan)
were used to produce amplimers for cloning and direct sequencing
respectively. Finally, Fragment C (HBV nt56-nt1824) was
obtained from a PCR amplification of Y2 HBV-DNA to which
an aliquot of genotype B HBV-DNA had been added. The
purpose of this experiment with in-tube control of genotype B was
to determine if the recombinant clones were being generated
during the PCR amplification. PCR products were gel-purified
and cloned into the PMD19-T vector (TAKARA, Japan)
according to the manufacturer’s instructions, and used to trans-
form JM109 competent cells (TAKARA, Japan). A minimum of
15 clones were sequenced from subjects with a mixed-strain
infection and three clones were sequenced from family members
with a single-strain infection. All sequencing of clones and PCR
products was performed by Invitrogen Ltd. (Shanghai, China).
Phylogenetic and Recombination Analysis
Genotypes of clones were determined by phylogenetic tree
analysis and recombination analysis. The sequences were assem-
bled using SeqMan II software (DNAStar Inc.). Sequence
alignments were performed using ClustalW and confirmed by
visual inspection. Phylogenetic trees were constructed by the
neighbour-joining (NJ) method (Saitou & Nei, 1987). To confirm
the reliability of the phylogenetic tree analysis, bootstrap
resampling and reconstruction were carried out 1000 times. A
phylogenetic tree analysis ` of HBV strains isolated from the mixed
infection family was compared with reference strains from
GenBank. Accession numbers are indicated on the tree. Bootstrap
values are shown along each main branch. The lengths of the
horizontal bars indicate the number of nucleotide substitutions per
site. The regions included in the analysis were the same with
fragment A, B and C or a little shorter. Phylogenetic and
molecular evolutionary analyses were conducted using MEGA
version 5 (Tamura, Peterson, Stecher, Nei, and Kumar 2011).
Recombination signals were initially detected by RDP3.b.4
software [13,14]. Bootscan, Geneconv and Siscan were used. The
highest acceptable P-value was 0.05. Bootscan and Siscan window
sizes were 300 bp, step size was 30, replicates for 100 times. A
genotype F sequence (GenBank accession numbers is X75658 and
X75663) was used as external reference. The precise map of
recombination was determined by split phylogenetic tree and
alignment. Split phylogenetic trees were constructed by the
method same as above. In alignment, each clone was compared
to reference C2, D1 and CD1 consensus sequences. We then
inspected the alignments to determine the identical crossover
sequences around the breakpoint within which the recombination
occurred.
Accession Number of the Sequences
GenBank accession number of reference sequences of HBV
genotype C2, D1, CD1 and CD2 are indicated in phylogenetic
tree. Accession Numbers of Y2 clones are JX036326-JX036359.
Results
Mixed-genotype Infections in HBV Cluster Families
Different HBV genotypes were found in three families among
15 families. The flow of participants in the study and family trees
of families with mixed genotypes/subgenotypes of HBV infection
are shown (Figure 1).
Family V had infected members across two generations and two
genotypes: In 2006, the mother (V1W) and daughter (V2F) were
infected with subgenotype D1 while the son (V2M) had a CD1
recombinant. In 2007, the daughter (V2F) had subgenotype D1
while other family members had HBV DNA levels below the
detection limit of the nested PCR assay.
Family Q had infected members across three generations and
two genotypes/subgenotypes. In 2006, the grandmother (Q1W)
and grandson (Q3M) were infected with CD1 recombinant while
father (Q2) and granddaughter (Q3F) had mixed infections of
genotype C2 and CD1 recombinants. In 2007, the same genotypes
were detected in all family members except that the granddaugh-
ter (Q3F) had an HBV DNA level below the detection limit of the
nested PCR assay.
Family Y had affected members across three generations and
three genotypes/subgenotypes. In 2006, the grandfather of family
Y (Y1) was infected with genotype C2 while grandmother (Y1W)
had mixed infections of CD1 and C2. Mother (Y2W) and
granddaughter (Y3F) were infected with the CD1 recombinant.
Father (Y2) had triplicate infections of genotype C2, D1 and CD
recombinant. Grandson’s (Y3M) serum was unavailable. In 2007,
the grandfather (Y1) and mother (Y2W) had HBV DNA levels
below the detection limit while the grandmother (Y1W) and
granddaughter (Y3F) had genotype CD1. Father (Y2) and
grandson (Y3M) had genotype D1.
Phylogenetic Analysis of Family Y, Family Q and Family V
A phylogenetic tree constructed from HBV nt 36-1110 from the
clones of family Y is given (Figure 2A). The clones (dotted) of
family Y exhibits three clusters on genotype C2, D1 and CD1.
The phylogenetic tree construct from HBV nt136-1110 from
the clones of families Q and V is given (Figure 2B). The clones of
Evidence of HBV C/D Recombinant
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genotypes C2, and CD1. The clones (indicated by black triangles)
from family V exhibit two clusters of subgenotypes D1 and CD1.
A phylogenetic tree constructed from HBV nt 36-1110 of novel
recombinants clones of Y2 is given in Figure 2C. The dotted
clones are from Y2. The topology of phylogenetic tree with
recombinants is totally different from typical trees. Recombinant
sequences blurred the typical branch,in other words, blurred the
typical genotype.
Recombination and Crossover Analysis of Quasi-species
of Y2
Results of recombination analysis of Y2 clones are as bellow:
Three kinds of analytical methods certificated the same re-
combination map. The initial pictures of the three methods were
all provided as supplemental figures. Recombination events
detected by RDP software are shown in Figure S1, S2, and S3.
Split phylogenetic trees constructed by MEGA software are shown
in Figure S4, S5, and S6, (clone number and fragment used to
construct tree are indicated beside each tree). Sequence alignments
are shown in Figure S7, S8, and S9.
The region where recombination breakpoints had the highest
probabilities was recognized as crossover region, which is a region
that one parental genotype switches to another. Upstream
sequence of crossover region will have specific mutation of one
genotype but with no specific mutation of another, downstream
just opposite. At the same time, these two genotypes should share
same sequence at crossover region. We indicated the crossover
region in direct alignment by black bars in Figure S3 initially and
marked it in recombination map by colorful bars in Figure 3A and
black bars in Figure 3B. The clonal sequences of 2006 showed 17
unique crossover regions in fragments A, B and C. We could not
identify any common motif within these sequences that might
suggest a common mechanism for crossovers in the HBV. The size
of switch region share the same sequence are different in different
strains, from 6–174 bp (6 bp for Y2M-2 clone in Figure S7 and
174 bp for Y2M-29 clone in Figure S8).
To illustrate the recombination map in a simple way. An
abbreviated alignment of fragment A, B and C are shown in
Figure 3B. Green and pink bars indicated the genotype C2 and D1
respectively. Black bars showed the crossover region. The aligned
sequences provide a snapshot of the recombinant HBV strains.
Genotype C2, D1 and CD1 recombinant clones of Y2 were all
used as parental sequences to recombine with each other to form
new recombinants. A series of novel recombinants were found in
three fragments.
In 15 clones of fragment A, there were five genotype C (Y2-
6,9,13,14,15,); two genotype D (Y2-11,12); one CD1 (Y2-10) and
seven novel different C/D recombination (Y2-1,2,4,7,8,3,5).
In 16 clones of fragment B, there were four genotype C (Y2-
23,71,78,75); seven genotype D (Y2-25, 27,79,76,72,22,210); one
CD1 (Y2-29) and four novel C/D recombinants (Y2-212,21
73,77).
Of the 56 clones of fragment C(in which genotype B HBVDNA
were added as an in-tube control to exclude the recombination by
PCR procedure), there were 32 pure genotype B clones; nine
genotype C clones(Y2-B10,B5,B8,B9,B13,B16.B17.B18,B24); five
genotype D clones(Y2-B22,B3,B4,B21,B23), two CD1 clones (Y2-
B1,B11) and eight novel C/D recombinants (Y2-
B6,B7,B14,B15,B19,B2,B12,B20). No recombinants of genotype
B were found.
Discussion
Recombination is one of the major mechanisms contributing to
the evolution of retroviruses [15]. Since the HBV has a reverse
transcription step in its life cycle, it is conceivable that
recombination also contributes to diversity in HBV genomes.
Although just four cases were observed with mixed genotype
Figure 1. Flow of participants in the study and family trees of family with mixed genotypes/subgenotypes HBV infection. Circles and
rectangles correspond to female and male individuals, respectively. Family name and birth date of the patients are indicated beside the circles and
rectangles. Subgenotype and the year of blood sampling are indicated inside the circles and rectangles. Family V with affected members across two
generations and two genotypes/subgenotypes. Family Q with affected members across three generations and two genotypes/subgenotypes. Family
Y with affected members across three generations and three genotypes/subgenotypes. Specially, father (Y2) of family Y with triplicate infection of
genotype C, D and CD recombinant in 2006. N.T: Not tested for HBV DNA level below the detection limit of the nested PCR assay or no serum was
available.
doi:10.1371/journal.pone.0038241.g001
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recombinants generated in the absence of selection and after
selection. Our result showed direct evidence of HBV recombina-
tion, with new information of recombining crossovers compared
with similar studies [16,17,18,19].
The recombination analysis of Y2 quasi-species showed variable
types of recombinant between genotype C2, D1 and CD1 in 2006.
Some studies show that hotspots of recombination most on the
boundary of ORFs [12,20]. Our results showed that two or more
strains of HBV can recombine with each other at any region along
the genome. Crossover regions can be hundreds or just several
base pairs, The length of crossover region is depends on the
location of it on HBV genome. If it is located in a conserved HBV
region, for another word, where many different genotypes share
the same sequence, the length of crossover region may be long. If it
is located in a non-conserved region, it may be very short. At the
same time, we found that the crossover region distributed totally at
random on HBV genome. Consistent with our results, in vitro
evidence showed the initial recombination events in a laboratory
system of MHV were almost entirely randomly distributed along
the sequence [21]. It was only after passage through cell culture,
with the opportunity for selection to remove less fit variants, that
crossover sites became ‘‘localized’’ to just a small area of the region
examined. Crucially, they also suggested initial products of
recombination may go undetected because of the action of strong
purifying selection which will remove new, deleterious combina-
tions of mutations. The conclusion is therefore an interpretation
for the genotype change of Y2. The Y2 presented multiple strain
infections of C2/D1/CD1 and many new recombinants with no
obvious dominant genotype strain in 2006. After 18 months,
however, all the type C2 and CD recombinant strains disappeared
while the D strain became dominant. A similar case of mixed HBV
genotype infection in which one genotype was lost and another
prevailed was previously described in patients with HBeAg
seroconversion [4,22].
Epidemiologically, HBV genotype CD1 and C2 are the most
common strains in ethnic minorities of northwest China with
CD2 and D1 as minor strains. Precise mapping of recombination
Figure 2. Phylogenetic tree construct by HBV nt 136-1110. (A) clones of family Y. Solid dots indicate the clones from Y1,Y1W,Y2W,Y3F and
Y3M; Solid triangles indicate the clones from Y2. Family names starting with number 7 means the samples collected in 2007 otherwise in 2006. Novel
recombinants of Y2 were excluded from the phylogenetic tree. (B) clones of family Q and family V. Solid dots indicate the clones from family Q; Solid
triangles indicate the clones from family V. A family name starting with number 7 means the samples collected in 2007, otherwise, in 2006. (C) Novel
recombinant clones of Y2. Solid dots indicate the clones from Y2.
doi:10.1371/journal.pone.0038241.g002
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recombinants. Virological differences among HBV genotypes
were demonstrated in vitroand in CHiM mice, with genotype C
having a higher replication capacity than D [23]. Why does the
replication-deficient genotype D virus predominate over replica-
tion-competent genotype C? As mixed HBV infections together
with recombination are rare, we have little knowledge about i
this situation. On the one hand, we know little about host impact
on different genotypes and recombinants. On the other hand, we
know little about interference and competition in the quasi-
species of mixed infection. In vitro results showed the replication
capacity of individual clone, exclude the influence of host and
other strains of quasi-species. An example from a ChiM mice
study showed that monoinfection of HBV/G in ChiM mice
display a very slow replication while coinfection with HBV/A
remarkably enhanced the replication of HBV/G. The replication
of HBV/G is heavily dependent on coinfection with other
genotypes. When HBV/G superinfected on other genotypes,
a rapidly takes over of HBV/G from original genotype were
observed, though they are indispensable [24]. This study
confirms that in a mixed infection system of different genotypes,
the replication capacity of a genotype may be different from that
of monoinfection. At the same time, replication capacity is not
the only factor to influence which strain will become dominant.
Variable recombinants found in our study may be mechanisti-
cally capable of genetic exchange, but strong selection guaran-
teed the elimination of hybrid genomes. The mechanism of
selection in mixed infection also needs more investigation.
We found mixed HBV genotypes infection with many novel
recombinants at one point in time, but just one genotype was
found 18 months later. This may indicate that the detectable
mixed infection and recombination has a limited time window due
to the sensitivity of detection or strong selection power of the host.
That’s why in most studies, we can identify a major genotype in
one patient. Even so, evolutionarily visible and invisible re-
combination of HBV could occur and play an important role by
generating genetic variation or reducing mutational load. How-
ever, this study had limitation, because recombination signals were
detected by RDP3 software and confirmed by split phylogenetic
tree and alignment, indicating the recombinant or recombinant-
like form should depend on the software. If we use another
software, the results might be different.
Studies of HBV in endemic areas throughout the world have
resulted in large numbers of full genome sequences available for
phylogenetic analysis enabling the identification of novel, mosaic
HBV genomes that appear to be the result of recombination
between previously known sequences [7,25,26]. One of the most
comprehensive analyses of putative HBV inter-genotype recombi-
nants showed the existence of 24 phylogenetically independent
HBV genomes involving all known human genotypes [27]. Some
of these recombinants are unique to individual subjects, but some
undergo expansion in specific populations and become recognized
as new genotypes or subgenotypes [12,28,29,30]. Four stages in
the process of generating popular HBV recombinant genomes
should be recognized. The first stage is the co-circulation of
different HBV strains or genotypes in the same geographic area.
The second is the existence of individuals who have been infected
with more than one strain of HBV. The third is the generation of
a novel recombinant strain(s) within an individual. The fourth is
the selection of a recombined strain with the ability to replicate
and be transmitted. Our data show the natural process of the
formation and selection of recombination though the recombinant
strains of Y2 that appeared in 2006 that were all removed from
samples in 2007.
By using phylogenetic trees and homology calculations, HBV
variants infecting humans are currently classified into ten
genotypes that differ from each other in nucleotide sequence by
7.5 to 13% [2,3]. There are some characteristic length differences
between the genotypes that facilitates their detection and
discrimination. However, as shown in Figure 2, existence of
a recombinant makes the topology of the phylogenetic tree totally
different from one with no recombinant. Recombinant strains
obscured the definition of genotypes. Based on the algorithm
creating a phylogenetic tree, sequences with high homologues
cluster together. With the same logic, recombinants always
clustered with the backbone parental sequence, in other words,
with which they have high similarity with the larger proportion of
the recombination region. Therefore, recombinants always seem
to be a subgenotype of their backbone parental sequence. Similar
to Y2-8 clone in Figure 2C, for recombinants with similar
proportion of both parental genotypes, the sequence shows
a divergent trend different from both parental genotypes.
Based on phylogenetic topology changes of different regions of
HBV, it was hypothesized that some of the genotypes that are
conventionally regarded as ‘‘pure,’’ actually were recombinant.
Genotype E strains show evidence of recombination with genotype
D at 1950–2500. new reported genotype ‘‘I’’ actually belongs to
genotype C. Furthermore, Subgenotype Ba possesses the re-
combination with genotype C at 1740 to 2485 [31,32,33].
Recombinants comprising regions with different histories have
important implications for the way we think about HBV evolution.
It means that there is no single phylogenetic tree that can describe
the evolutionary relationships between genotypes.
In conclusion, mixed HBV genotypes infection with many novel
recombinants at one point in time ended up with just one genotype
18 months later in this study. This may indicate that the detectable
mixed infection and recombination have a limited time window
due to the sensitivity of detection or strong selection power of the
host. Also, as the recombinant or recombinant-like nature of HBV
precludes the possibility of a ‘‘true’’ phylogenetic taxonomy, a new
standard may be required for classifying HBV sequences.
Figure 3. Alignment and recombination crossover regions found in Y2 clones. (A) Frequency and distribution of the recombination
crossover regions found in Y2 clones along the HBV genome. The bars indicate the number of clones (y axis) showing recombination crossover
regions at each site. The 1-3215 of x axis was consistent with the nt1-3215 of HBV genome. Different colors represent the sites find from clones of
different PCR region: pink bars for fragment A, grey bars for fragment B and green bars for fragment C. (B) Alignment of fragment A (HBV nt 2813-0-
1667). Y2-1912: clones from fragment A of Y2 patients. (C) Alignment of fragment B (HBV nt 1822-0-257). Y2-219212: clones from fragment B of Y2
patients. (D) Alignment of fragment C (HBV nt 57-1818) of Y2 clones. Y2-B19B22: clones from fragment C of Y2 patients. The number on the x axis was
consistent with the site of nucleotides of HBV genome. Solid green lines are genotype C2, solid pink lines are genotype D1, speckled green lines are
the C2 component of genotype recombinant CD1 and speckled pink lines are the D1 component of recombinant genotype CD1. The black lines are
sequence that is common to the recombining genotypes, and within which the recombination probably occurred. C2 (242) is the consensus
sequence formed by 242 subgenotype C2 sequences from GenBank. D1 (88) is the consensus sequence formed by 88 subgenotype D1 sequences
from GenBank. CD1 (33) is the consensus sequence formed by CD1 recombinant sequences from GenBank.
doi:10.1371/journal.pone.0038241.g003
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Figure S1 Recombination map of fragment A created by
RDP software.
(TIF)
Figure S2 Recombination map of fragment B created by
RDP software.
(TIF)
Figure S3 Recombination map of fragment C created by
RDP software.
(TIF)
Figure S4 Split phylogenetic trees constructed by MEGA
software. clone number and fragment used to construct trees are
indicated beside each tree.
(TIF)
Figure S5 Split phylogenetic trees constructed by MEGA
software. clone number and fragment used to construct trees are
indicated beside each tree.
(TIF)
Figure S6 Split phylogenetic trees constructed by MEGA
software. clone number and fragment used to construct trees are
indicated beside each tree.
(TIF)
Figure S7 Alignment of fragment A(HBV nt 2813-0-
1667)of Y2 clones. Deep green lines are genotype C2, deep
pink lines are genotype D1, light green lines are the C2 component
of genotype recombinant CD1 and light pink lines are the D1
component of recombinant genotype CD1. The black lines are
sequence that is common to the recombining genotypes, and
within which the recombination probably occurred. C2 (242):
consensus sequence formed by 242 subgenotype C2 sequences
from GenBank. D1 (88): consensus sequence formed by 88
subgenotype D1 sequences from GenBank. CD1 (33): consensus
sequence formed by CD1 recombinant sequences from GenBank.
Y2-1912: clones from fragment A of Y2 patients.
(DOC)
Figure S8 Alignment of fragment B(HBV nt 1822-0-257)
of Y2 clones. Deep green lines are genotype C2, deep pink lines
are genotype D1, light green lines are the C2 component of
genotype recombinant CD1, light pink lines are the D1
component of recombinant genotype CD1. The black lines are
sequence that is common to the recombining genotypes, and
within which the recombination probably occurred. C2 (242):
consensus sequence formed by 242 subgenotype C2 sequences
from GenBank. D1 (88): consensus sequence formed by 88
subgenotype D1 sequences from GenBank. CD1 (33): consensus
sequence formed by CD1 recombinant sequences from GenBank.
Y2-219212: clones from fragment B of Y2 patients.
(DOC)
Figure S9 Alignment of fragment C(HBV nt 57-1818) of
Y2 clones. Deep green lines are genotype C2, deep pink lines are
genotype D1, light green lines are the C2 component of genotype
recombinant CD1, light pink lines are the D1 component of
recombinant genotype CD1. The black lines are sequence that is
common to the recombining genotypes, and within which the
recombination probably occurred. C2 (242): consensus sequence
formed by 242 subgenotype C2 sequences from GenBank. D1
(88): consensus sequence formed by 88 subgenotype D1 sequences
from GenBank. CD1 (33): consensus sequence formed by CD1
recombinant sequences from GenBank. B1 `B22: clones from
fragment C of Y2 patients.
(DOC)
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